Buy One Get One free -Llimited Time Offer X
Vancotroy is a prescription medicine that is available as a Injection. Bacterial Infections, Peritonitis are some of its major therapeutic uses. Other than this, Vancotroy has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Vancotroy depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Vancotroy can also lead to other problems, which have been listed below. Usually, these side effects of Vancotroy go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Vancotroy's effect is Severe during pregnancy and Safe for lactating mothers. Warnings related to Vancotroy's effects on the liver, heart and kidney, if any, have been listed below.
Vancotroy is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Other contraindications of Vancotroy have been discussed in the sections ahead.
Besides this, Vancotroy may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Vancotroy is safe while driving, and is is addictive in nature.
Vancotroy is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Vancotroy is used -
Moderate
Mild
Is the use of Vancotroy safe for pregnant women?
Pregnant women may get severe side effects after taking Vancotroy. If you are pregnant, do not take Vancotroy without a doctor's advice.
Is the use of Vancotroy safe during breastfeeding?
Vancotroy is safe for breastfeeding women.
What is the effect of Vancotroy on the Kidneys?
Vancotroy may have mild side effects on the kidneys.
What is the effect of Vancotroy on the Liver?
There are no any side effects of Vancotroy on the liver.
What is the effect of Vancotroy on the Heart?
You can take Vancotroy without any fear of damage to the heart.
Vancotroy should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vancotroy unless your doctor advises you to do so -
Is this Vancotroy habit forming or addictive?
Forming a habit of Vancotroy has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Vancotroy will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Vancotroy only on doctor's advice.
Is it able to treat mental disorders?
No, Vancotroy is not used to treat mental disorders.
Interaction between Food and Vancotroy
You can take Vancotroy with food.
Interaction between Alcohol and Vancotroy
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Vancotroy.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vancomycin Hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 757
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1246-1248